Skip to main content
Log in

Treatment improves serotonin transporter binding and reduces binge eating

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Serotonin (5-HT) is involved in the control of eating behaviour by inhibiting food intake. Obese women with binge-eating disorder (OB-BED) were recently found to have reduced 5-HT transporter binding.

Objectives

The aim of this study was to investigate the effect of a successful treatment on 5-HT transporters in OB-BED.

Methods

The 5-HT transporter binding of seven OB-BED was measured by single-photon emission computed tomography (SPECT), by using iodine-123-labelled nor-β-CIT as a tracer, before treatment and after successful treatment, when the OB-BED were asymptomatic. Treatment consisted of group psychotherapy and fluoxetine medication. The control subjects, six obese women without eating disorders, were also studied twice by using SPECT.

Results

The 5-HT transporter binding of the symptomatically recovered OB-BED increased significantly (24±22%) after treatment, whereas in the control group, binding remained unchanged.

Conclusions

The results tentatively suggest that 5-HT transporter binding in OB-BED is an adaptive mechanism, which can be affected by treatment. Furthermore, there seems to be a link between improved 5-HT transporter binding and reduced binge eating.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  • American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington D.C.

  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:53–63

    Google Scholar 

  • Fairburn CG, Cooper Z (1993) The Eating Disorder Examination. In: Fairburn CG, Wilson GT (eds) Binge eating: nature, assessment, and treatment. Guilford, New York, pp 317–332

  • Gormally J, Black S, Daston S, Rardin D (1982) The assessment of binge eating severity among obese persons. Addict Behav 7:47–55

    CAS  PubMed  Google Scholar 

  • Henderson M, Freeman CP (1987) A self-rating scale for bulimia. The BITE. Br J Psychiatry 150:18–24

    CAS  PubMed  Google Scholar 

  • Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann JJ (1998) Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry 55:927–935

    Article  CAS  PubMed  Google Scholar 

  • Kuikka JT, Tammela L, Bergstrom KA, Karhunen L, Uusitupa M, Tiihonen J (2001a) Effects of ageing on serotonin transporters in healthy females. Eur J Nucl Med 28:911–913

    Article  CAS  PubMed  Google Scholar 

  • Kuikka JT, Tammela L, Karhunen L, Rissanen A, Bergstrom KA, Naukkarinen H, Vanninen E, Karhu J, Lappalainen R, Repo-Tiihonen E, Tiihonen J, Uusitupa M (2001b) Reduced serotonin transporter binding in binge eating women. Psychopharmacology 155:310–314

    Article  CAS  PubMed  Google Scholar 

  • Leibowitz SF, Alexander JT (1998) Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44:851–864

    CAS  PubMed  Google Scholar 

  • Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brucke T (2000) Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med 41:36–44

    Google Scholar 

  • Spitzer RL, Yanovski S, Wadden T, Wing R, Marcus MD, Stunkard A, Devlin M, Mitchell J, Hasin D, Horne RL (1993) Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 13:137–153

    CAS  PubMed  Google Scholar 

  • Steiger H, Young SN, Kin NM, Koerner N, Israel M, Lageix P, Paris J (2001) Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 31:85–95

    Article  CAS  PubMed  Google Scholar 

  • Tauscher J, Pirker W, de Zwaan M, Asenbaum S, Brucke T, Kasper S (1999) In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment. Eur Neuropsychopharmacol 9:177–179

    Article  CAS  PubMed  Google Scholar 

  • Tauscher J, Pirker W, Willeit M, de Zwaan M, Bailer U, Neumeister A, Asenbaum S, Lennkh C, Praschak-Rieder N, Brucke T, Kasper S (2001) [123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 49:326–332

    Article  CAS  PubMed  Google Scholar 

  • van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, Baldwin RM, Innis RB (2000) Age-related decline in central serotonin transporter availability with [123I] beta-CIT SPECT. Neurobiol Aging 21:497–501

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The study was supported by grants from the Kuopio University Hospital (EVO-5136), the Finnish Cultural Foundation (00011067) and the Academy of Finland, Research Council for Health (28327). The authors thank the personnel of the Department of Clinical Physiology and Nuclear Medicine.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liisa I. Tammela.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tammela, L.I., Rissanen, A., Kuikka, J.T. et al. Treatment improves serotonin transporter binding and reduces binge eating. Psychopharmacology 170, 89–93 (2003). https://doi.org/10.1007/s00213-003-1519-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1519-6

Keywords

Navigation